Comparative efficacy of oral and intravenous granisetron for the prevention of acute chemotherapy-induced emesis

This publication has 29 references indexed in Scilit:

• A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy
  Cancer, 1996
• Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: a dose-ranging study
  Clinical Therapeutics, 1995
• Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis
  Annals of Oncology, 1994
• New directions for anti-emetic research
  Annals of Oncology, 1994
• Potential for combination therapy with the new antiserotonergic agents
  European Journal Of Cancer, 1993
• Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics
  Trends in Pharmacological Sciences, 1991
• Methodology of antiemetic trials: A review
  Annals of Oncology, 1991
• Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
  Journal of Clinical Oncology, 1987
• Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism
  British Journal of Pharmacology, 1986
• Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting
  New England Journal of Medicine, 1981